Sign up to save your podcasts
Or
Share E115: Benralizumab for EGPA - the MANDARA Study
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E115: Benralizumab for EGPA - the MANDARA Study
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
View all episodes
By Michael Putman
4.9
111111 ratings
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
315 Listeners
JAMA Clinical Reviews
496 Listeners
Rheumnow Podcast
122 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
Core IM | Internal Medicine Podcast
1,109 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
69 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
171 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
19 Listeners